Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
NCT07507838
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
VV913 4mg group
DRUG:
VV913 8mg group
DRUG:
VV913 15mg group
Sponsor
Vigonvita Life Sciences